Physician

Anteneh M Feyissa, MD

According to 2025 Medicare claims, Anteneh Feyissa, MD (NPI: 1245542547) practices epileptologists in the Jacksonville, FL market, with the plurality of this provider's patient population coming from Duval, FL. This provider's primary affiliated billing organization is MAYO CLINIC JACKSONVILLE (NPI: 1790772317; TIN: 593337028) and primary practice location at 32224-1865.

Feyissa's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 203 traditional Medicare patients, billed 298 HCPCS/CPT codes, and received $27,732 in Medicare payments. The top billing code was 95720 (Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional). Part D data shows 550 prescription claims across 85 beneficiaries totaling $563,812 in drug costs, led by Xcopri (Cenobamate). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $19,555 and ending at $27,732. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $16,824 to $563,812. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$27K$54K2015 Medicare payment: $19,555 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $19,466 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $51,459 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $53,897 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $44,934 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $28,234 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $36,770 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $26,027 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $36,019 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $27,732 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157688$19,555
2016133189$19,466
2017303547$51,459
2018290541$53,897
2019243439$44,934
2020218303$28,234
2021260389$36,770
2022219321$26,027
2023220345$36,019
2024203298$27,732

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$333K$667K2015 Drug cost: $16,824 (USD; Tot_Drug_Cst)2016 Drug cost: $53,911 (USD; Tot_Drug_Cst)2017 Drug cost: $202,614 (USD; Tot_Drug_Cst)2018 Drug cost: $332,018 (USD; Tot_Drug_Cst)2019 Drug cost: $355,282 (USD; Tot_Drug_Cst)2020 Drug cost: $399,652 (USD; Tot_Drug_Cst)2021 Drug cost: $531,353 (USD; Tot_Drug_Cst)2022 Drug cost: $666,892 (USD; Tot_Drug_Cst)2023 Drug cost: $609,259 (USD; Tot_Drug_Cst)2024 Drug cost: $563,812 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201518116$16,824
201639189$53,911
201775372$202,614
201890473$332,018
201997582$355,282
2020102691$399,652
2021108743$531,353
2022106818$666,892
2023104680$609,259
202485550$563,812

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
95720Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional2958$147
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more3237$92
95819Measurement of brain wave activity (eeg), awake and asleep4141$42
95816Measurement of brain wave activity (eeg), awake and drowsy4141$41
95812Measurement of brain wave activity (eeg), 41-60 minutes2727$35

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XcopriCenobamate522,428$115,187
Lamictal XrLamotrigine14840$98,522
OnfiClobazam11570$42,644
BriviactBrivaracetam15630$36,219
ValtocoDiazepam15362$34,754

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Anteneh M. Feyissa, MD?

Tedicare shows public-source Medicare data for Anteneh M. Feyissa, MD (NPI 1245542547), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anteneh M. Feyissa, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Anteneh M. Feyissa, MD?

Anteneh M. Feyissa, MD is linked to MAYO CLINIC JACKSONVILLE (billing NPI 1790772317) in the available physician profile data.

Does Anteneh M. Feyissa, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.